OpenAI COO Brad Lightcap says he hopes everyone gets access to GPT-5 “by the end of the week.” Lightcap talks about the launch of the AI startup's latest model with Caroline Hyde on “Bloomberg Tech.”

OpenAI COO Brad Lightcap says he hopes everyone gets access to GPT-5 &ldquo;by the end of the week.&rdquo; Lightcap talks about the launch of the AI startup's latest model with Caroline Hyde on &ldquo;Bloomberg Tech.&rdquo;

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

OpenAI COO Brad Lightcap Talks GPT-5

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/085529ee-6164-426b-bebc-b33301111880/transcript

New York Representative  Nicole Malliotakis (R) joins Joe Mathieu on "Balance of Power" to talk about the looming government funding deadline and the continued debate over ICE. 

New York Representative &nbsp;Nicole Malliotakis (R) joins Joe Mathieu on "Balance of Power" to talk about the looming government funding deadline and the continued debate over ICE.&nbsp;

New York Representative  Nicole Malliotakis (R) Talks Funding Deadline, ICE Reform

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/80da4061-10c7-4dc3-9b25-b3e801349397/transcript

Qualcomm CEO Cristiano Amon joins "Bloomberg Tech" to talk about the outlook for the company with rising memory costs and component shortages.  

Qualcomm CEO Cristiano Amon joins "Bloomberg Tech" to talk about the outlook for the company with rising memory costs and component shortages.&nbsp;&nbsp;

Qualcomm CEO Cristiano Amon Talks Earnings, Component Shortages

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3c176d84-2711-46b6-a760-b3e8012c86c2/transcript

Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they &ldquo;feel good about the progress.&rdquo; He speaks to Katie Greifeld.

Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e7fdd99d-a445-43ad-a271-b3e8000c318c/transcript

OpenAI COO Brad Lightcap Talks GPT-5

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips